These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Comparative study between pancuronium bromide and d-tubocurarine]. Costa PN Rev Bras Anestesiol; 1971; 21(4):721-7. PubMed ID: 4259786 [No Abstract] [Full Text] [Related]
27. A retrospective analysis of long-term use of nondepolarizing neuromuscular blocking agents in the intensive care unit, and guidelines for drug selection. Clarens DM; Kelly KJ; Gilliland SS; Kohls PK; Nahum A; Vance-Bryan K Pharmacotherapy; 1993; 13(6):647-55. PubMed ID: 7905621 [TBL] [Abstract][Full Text] [Related]
28. [Notes on a new muscle relaxant: pancuronium bromide]. Soares EL; Massa L; Costa MH Rev Bras Anestesiol; 1971; 21(4):712-20. PubMed ID: 4259785 [No Abstract] [Full Text] [Related]
29. [Clinical study of pancuronium bromide]. Madre F; Cambe M; Sonnet M; Montagne J Anesth Analg (Paris); 1972; 29(1):35-42. PubMed ID: 4262611 [No Abstract] [Full Text] [Related]
30. A clinical comparison of pancuronium with d-tubocurarine. McDowell SA; Clarke RS Anaesthesia; 1969 Oct; 24(4):581-90. PubMed ID: 4187021 [No Abstract] [Full Text] [Related]
31. Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids. Barohn RJ; Jackson CE; Rogers SJ; Ridings LW; McVey AL Muscle Nerve; 1994 Jun; 17(6):647-54. PubMed ID: 7910951 [TBL] [Abstract][Full Text] [Related]
32. [Clinical use of pancuronium bromide (Pavulon)]. Nicoletti RL; Soares PM; Pereira MS; dos Oliveira MP; Hamamura J Rev Bras Anestesiol; 1971; 21(3):309-13. PubMed ID: 4257836 [No Abstract] [Full Text] [Related]
33. The effect of renal failure and hyperkalemia on the duration of pancuronium neuromuscular blockade in man. Miller RD; Stevens WC; Way WL Anesth Analg; 1973; 52(4):661-6. PubMed ID: 4352150 [No Abstract] [Full Text] [Related]
34. [Pancuronium bromide, Pavulon (muscle relaxant), Organon. (1st experience at high altitude)]. Castaños CC Rev Esp Anestesiol Reanim; 1972 Jul; 19(3):344-6. PubMed ID: 4262639 [No Abstract] [Full Text] [Related]
37. Effect of pancuronium bromide on plasma histamine levels in man. Dobkin AB; Arandia HY; Levy AA Anesth Analg; 1973; 52(5):772-5. PubMed ID: 4269753 [No Abstract] [Full Text] [Related]
38. [Clinical comparative study of pancuronium and succinylcholine in high risk patients]. de Bañuelos JA; Sánches R; Cortés T Rev Bras Anestesiol; 1971; 21(4):734-41. PubMed ID: 4259788 [No Abstract] [Full Text] [Related]
39. The impact of practice guidelines on prescribing patterns of nondepolarizing neuromuscular blocking agents. Tschida SJ; Hoey LL; Vance-Bryan K Pharmacotherapy; 1996; 16(5):899-904. PubMed ID: 8888085 [TBL] [Abstract][Full Text] [Related]
40. [Use of pancuronium bromide in 474 general anesthesias]. Villoria López J; Cuevas Mateos F; Chico Azanza JL; Morato Morato D Rev Esp Anestesiol Reanim; 1973 Jul; 20(3):379-82. PubMed ID: 4269904 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]